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Hepatocytes derived from human embryonic stem cells (hESCs) are an attractive cell 
source for regenerative medicine. We previously reported the differentiation of hESCs 
into alpha-fetoprotein (AFP)-producing endodermal cells using extracellular matrix and 
growth factors. Moreover, we also reported the establishment of the MLSgt20 cell line, 
which was derived from mesenchymal cells residing in murine fetal livers and 
accelerated the hepatic maturation of both murine hepatic progenitor cells and murine 
ESCs. In this study, hESC-derived AFP-producing cells were isolated using a flow 
cytometer and co-cultured with MLSgt20 cells. The co-cultured hESC-derived 
AFP-producing cells had the immunocytologic characteristics of hepatocytes, expressed 
mature hepatocyte-markers by RT-PCR, and displayed higher hepatocyte functions, 
including ammonia removal ability, cytochrome P450 3A4/7 activity, and the ability to 
produce and store glycogen. However, the MLSgt20 cells did not directly cause 
undifferentiated hESCs to mature into hepatocyte-like cells. In conclusion, the 
co-culture method was successfully shown to differentiate hESC-derived endodermal 
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cells into functional hepatocyte-like cells. 
 
 




Hepatocytes derived from human embryonic stem cells (hESCs) are a 
potential cell source for cell transplantation, bio-artificial livers, and drug discovery 
systems (Cai, et al., 2007, D'Amour, et al., 2005, Duan, et al., 2007). However, it has 
been difficult to obtain fully functional hepatocytes from hESCs, partly because there is 
still only limited knowledge of hepatic developmental biology and molecular 
mechanisms (Chen, et al., 2007, Ek, et al., 2007, Schuldiner, et al., 2000).  
We previously reported that mesenchymal cells residing in murine fetal livers 
(CD45−CD49f±Thy1+gp38+ cells) promoted hepatic maturation of hepatic progenitor 
cells (HPCs) (Hoppo, et al., 2004, Kamo, et al., 2007) and murine ESC-derived 
alpha-fetoprotein (AFP)-producing cells (Ishii, et al., 2005). Moreover, we successfully 
established the MLSgt20 cell line from CD45−CD49f±Thy1+gp38+ murine fetal liver 
mesenchymal cells (Fukumitsu, et al., 2009). The MLSgt20 cells promoted the 
maturation of both murine HPCs and murine ESC-derived AFP-producing cells into 
functional hepatocyte-like cells. We also reported an effective method for the 
differentiation of hESCs into AFP-producing endodermal cells using growth factors and 
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extracellular matrix (Ishii, et al., 2008). A hESC line expressing enhanced green 
fluorescent protein (EGFP) under the control of the human AFP enhancer/promoter was 
generated and differentiated into AFP-EGFP-positive cells with approximately 20% 
efficiency. However, it was technically difficult to further differentiate the 
hESC-derived AFP-producing cells into functional hepatocytes.    
In the present study, we sought to make it possible for hESC-derived 
AFP-producing cells to mature into functional hepatocyte-like cells in vitro via 




Materials and Methods 
Cell Culture 
 The MLSgt20 cells were cultured in Dulbecco’s modified Eagle’s medium 
(DMEM) supplemented with10% Fetal bovine serum (FBS; JRH biosciences, Lenexa, 
KS), 1 mM sodium pyruvate (Sigma-Aldrich, St. Louis, MO), 10 mM nicotinamide 
(Sigma-Aldrich), 2 mM L-ascorbic acid phosphate (Wako Pure Chemical, Osaka, 
Japan), insulin-transferin-selenium supplement (Gibco, Grand Island, NY), 0.1 M 
dexamethasone (Sigma-Aldrich), and 20 ng/ml hepatocyte growth factor (HGF; R&D 
Systems Inc., Minneapolis, MN) on collagen type I-coated dishes (AGC techno glass, 
Chiba, Japan). The transgenic hESCs that expressed EGFP under the control of human 
AFP enhancer/promoter were originally derived from the KhES3 line and were cultured 
on a feeder layer of mouse embryonic fibroblasts as described previously (Ishii, 
Fukumitsu, Yasuchika, Adachi, Kawase, Suemori, Nakatsuji, Ikai and Uemoto, 2008, 
Suemori, et al., 2006).  
 
Differentiation into hepatocyte-like cells 
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 To differentiate hESCs into endodermal cells, hESCs were cultured as 
described previously (Ishii, Fukumitsu, Yasuchika, Adachi, Kawase, Suemori, Nakatsuji, 
Ikai and Uemoto, 2008). In brief, the hESCs were transferred to Matrigel-coated dishes 
and cultured in PRMI1640-based medium with 100 ng/ml activin A (R&D Systems 
Inc.) for four days and subsequently with 20 ng/ml HGF for five days. The 
differentiated cells were dissociated with 0.05% trypsin (Gibco) and EDTA (Dojindo 
Laboratories, Kumamoto, Japan) solution, followed by resuspension in Hank’s balanced 
salt solution supplemented with 3% FBS. The EGFP-positive AFP-producing cells were 
separated using a FACSVantage SE (BD Biosciences, Franklin Lakes, NJ). In order to 
form cell aggregates, the sorted EGFP-positive cells were either cultured alone or 
co-cultured with the dissociated MLSgt20 cells in a 1:1 mixture in Sumilon Celltight 
Spheroid 96-well plates (Sumitomo Bakelite Co., Ltd., Tokyo, Japan) at a density of 1 × 
10
4 
cells per well in DMEM supplemented with 10% FBS, 1 mM sodium pyruvate, 10 
mM nicotinamide, 0.2 mM L-ascorbic acid phosphate, insulin-transferin-selenium 
supplement, 0.1 M dexamethasone, 20 ng/ml HGF, and 10 ng/ml oncostatin M (R&D 
Systems Inc.) for seven days after the cell sorting. Correspondingly, the undifferentiated 
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hESCs were dissociated using 0.05% trypsin and EDTA solution and subsequently 
co-cultured in a 1:1 mixture with the MLSgt20 cells to generate cell aggregates at the 
same cell density. The dissociated MLSgt20 cells were also cultured to form cell 
aggregates. These spheroids were inoculated into 1:80 diluted Matrigel (BD 
Biosciences) coated-dishes at a density of 6 to 8 spheroids/cm
2
 and then were cultured 
for 14 days. Flow diagrams of the culture protocol are summarized in Fig. 1. 
 
Immunostaining 
 The cultured cells were fixed and stained as previously described (Ishii, 
Fukumitsu, Yasuchika, Adachi, Kawase, Suemori, Nakatsuji, Ikai and Uemoto, 2008, 
Ishii, Yasuchika, Fujii, Hoppo, Baba, Naito, Machimoto, Kamo, Suemori, Nakatsuji and 
Ikai, 2005). The primary antibodies used in the present study were as follows: 
anti-human AFP (Dako, 1:200), anti-human albumin (Bethyl, Montogomery, TX, 1:200), 
anti-human CYP3A4/7 (Enzo Life Science, Plymouth Meeting, PA, 1:500), and 
anti-mouse gp38 (a kind gift of Dr. Andrew G. Farr, University of Washington
 
School 




Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR) 
 An RT-PCR analysis was performed as described previously (Ishii, Fukumitsu, 
Yasuchika, Adachi, Kawase, Suemori, Nakatsuji, Ikai and Uemoto, 2008, Ishii, 
Yasuchika, Fujii, Hoppo, Baba, Naito, Machimoto, Kamo, Suemori, Nakatsuji and Ikai, 
2005, Ishii, et al., 2007). Primers were generated for the following genes: human Nanog, 
human Oct-3/4, human GATA4, human AFP, human albumin, human tyrosine 
aminotransferase (TAT), human tryptophan-2,3-dioxgenase (TO), human cytochrome 
P450 3A4/7 (CYP3A4/7), and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) of 
human and mouse genes. The primer sequences and PCR conditions are summarized in 
Table 1. 
 
Hepatocyte Function Analyses 
In order to examine hepatocyte-related functions, the ammonia removal 
ability, CYP3A4/7 activity, and the ability to synthesize and store glycogen were 
analyzed. The ammonia concentrations in the media after 24-hour cultures were 
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measured as described previously (Ishii, Yasuchika, Fujii, Hoppo, Baba, Naito, 
Machimoto, Kamo, Suemori, Nakatsuji and Ikai, 2005). CYP3A4/7 activity was 
examined using P450-Glo CYP3A4 Assays (Luciferin-PFBE; Promega, WI, USA) 
according to the manufacturer’s protocol. For CYP3A4/7 induction studies, cultured 
cells were treated in the presence of 50 M dexamethasone for 48 hours. The 
dexamethasone was dissolved with 99.5% ethanol. Huh7 (American Type Culture 
Collection, Manassas, VA), a human hepatocellular carcinoma cell line, was used as a 
control. Periodic acid-Shiff (PAS) staining was performed to detect the presence of 
intracellular glycogen, according to the established standard protocol (Hoppo, Fujii, 
Hirose, Yasuchika, Azuma, Baba, Naito, Machimoto and Ikai, 2004, Ishii, Yasuchika, 
Fujii, Hoppo, Baba, Naito, Machimoto, Kamo, Suemori, Nakatsuji and Ikai, 2005). 
 
Statistical analysis 
All experiments were repeated at least three times. The results are presented 
as the mean ± SD. The statistical analyses were performed using Student’s t- or 




Formation of cell aggregates 
Spheroid cultures were utilized to mature hESCs into functional hepatocytes. 
Although the MLSgt20 cells could form cell spheroids (Fig. 2a), the sorted 
EGFP-positive AFP-producing cells per se did not form cell aggregates in the absence 
of MLSgt20 cells. The trypsinized undifferentiated hESCs did not form cell aggregates 
in the absence of MLSgt20 cells either (data not shown). However, these cells could 
form spherical cell aggregates in the presence of MLSgt20 cells (Fig. 2b, c). These 
spheroids were placed on Matrigel-coated dishes and some of them spread throughout 
the culture dishes (Fig. 2e, f). The spreading cells formed a monolayer that was 
morphologically identical or very similar to MLSgt20 cells (Fig. 2d, g). Among these 
monolayer cells, there were piled-up colonies consisting of polygonal hepatocyte-like 
cells (Fig. 2h). 
 




Immunocytological assays were performed in order to characterize the 
differentiated cells. Immunostaining revealed that the spreading monolayer cells did not 
express human AFP, albumin, or CYP3A4/7 (Fig. 3a-c). The cells expressed murine 
gp38, which was one of the cell surface markers of the MLSgt20 cells (Fig. 3d). 
However, the piled-up colonies of the co-cultured hESC-derived AFP-producing cells 
expressed human AFP (Fig. 3e) and albumin (Fig. 3f), and some cells were binucleate 
(Fig. 3g). In contrast, these colonies did not express murine gp38 (Fig. 3i). Less than 
10% of the piled-up cells expressed CYP3A4/7 (Fig. 3h). These results suggested that 
the MLSgt20 cells predominantly proliferated and formed a monolayer surrounding the 
hESC-derived colonies. Although all the colonies expressed AFP and/or albumin, some 
colonies primarily expressed AFP, while some primarily expressed albumin, and others 
expressed both (Fig. 3j). Therefore, the co-cultured hESCs were heterogeneous cell 
populations at various stages of differentiation.   
 
Hepatocyte-related marker expression 
RT-PCR revealed that the hESC-derived AFP-producing cells co-cultured 
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with the MLSgt20 cells expressed some mature hepatocyte markers, including albumin, 
TAT, TO, and CYP3A4/7 (Fig. 4). Although their expression pattern was similar to that 
of adult livers, the co-cultured hESC-derived AFP-producing cells still expressed AFP 
and GATA4, unlike the adult livers. These results were consistent with the 
immunocytological observations mentioned above. However, the undifferentiated 
hESCs co-cultured with MLSgt20 cells did not express the hepatocyte-related markers, 
with the exception of weak expressions of AFP and TAT, whereas they still expressed 
undifferentiated ESC markers, including Nanog and Oct-3/4. 
 
Hepatocyte function analyses 
The ammonia removal ability (Fig. 5a), CYP3A4/7 activity (Fig. 5b), and 
glycogen synthesis and storage ability (Fig. 5c, d) were measured in order to evaluate 
the extent of the hepatocyte functions. The hESC-derived AFP-producing cells 
co-cultured with MLSgt20 cells had a significantly greater ability to remove ammonia 
than the MLSgt20 cells alone or the undifferentiated hESCs co-cultured with MLSgt20 
cells. Furthermore, the hESC-derived AFP-producing cells co-cultured with MLSgt20 
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cells displayed a higher CYP3A4/7 activity than the other cell groups, even in the 
absence of dexamethasone-mediated CYP3A4/7 induction. The CYP3A4/7 activity of 
the hESC-derived AFP-producing cells co-cultured with MLSgt20 cells displayed an 
approximately 1.45-fold increase by dexamethasone with statistical significance. 
However, an extended culture period did not increase the degree of CYP3A4/7 activity 
(Supplementary Fig. 1). The Huh7 cells showed a lower level of CYP3A4/7 activity 
than the co-cultured hESC-derived AFP-producing cells. In addition, dexamethasone 
did not increase the CYP3A4/7 activity of Huh7. Moreover, the piled-up colonies of the 
co-cultured hESC-derived AFP-producing cells were positive for PAS staining, while 
the flat monolayer cells, which were morphologically supposed to be MLSgt20 cells, 
were not stained by PAS staining. These results indicated that the hESC-derived 
AFP-producing cells co-cultured with MLSgt20 cells possessed the ability to produce 




The maturation of murine fetal hepatoblasts into hepatocytes required direct 
contact with mesenchymal cells residing in fetal livers (Hoppo, Fujii, Hirose, Yasuchika, 
Azuma, Baba, Naito, Machimoto and Ikai, 2004, Kamo, Yasuchika, Fujii, Hoppo, 
Machimoto, Ishii, Fujita, Tsuruo, Yamashita, Kubo and Ikai, 2007). The mesenchymal 
cells that accelerated the hepatic cell maturation were defined as the 
CD45−CD49f±Thy1+gp38+ cell fraction. Based on these findings, the MLSgt20 cell 
line was established from this cell fraction by transfection of the SV40 large T antigen 
gene (Fukumitsu, Ishii, Yasuchika, Amagai, Saitoh, Kawamoto, Kawase, Suemori, 
Nakatsuji, Ikai and Uemoto, 2009). Co-culture with the MLSgt20 cell line promoted the 
hepatic maturation of murine hepatic progenitor cells as well as murine ESC-derived 
AFP-producing endodermal cells. The use of media conditioned with the MLSgt20 cells 
had no effect on hepatic maturation. Because it was unclear whether the MLSgt20 cells 
affected the hepatic maturation of hESCs, we sought to establish a method to mature 
hESCs into functional hepatocytes using MLSgt20 cells.  
It was technically difficult to culture hESC-derived cells after cell sorting 
16 
 
because hESCs were vulnerable to trypsin treatment (Hasegawa, et al., 2007, Suemori, 
Yasuchika, Hasegawa, Fujioka, Tsuneyoshi and Nakatsuji, 2006). However, co-culture 
with MLSgt20 cells enabled the sorted hESC-derived AFP-producing cells to survive 
and form cell aggregates. Furthermore, the co-cultured hESC-derived AFP-producing 
cells expressed hepatic markers and hepatocyte functions, including ammonia removal 
ability and glycogen synthesis/storage capability. Moreover, dexamethasone induced the 
CYP3A4/7 activity of the co-cultured cells. Although the Huh7 cells also displayed 
CYP3A4/7 activity, it was not induced by dexamethasone. These results indicated that 
the co-cultured hepatocyte-like cells derived from hESCs displayed physiological 
metabolic reactions. However, the results of immunostaining and RT-PCR revealed that 
the co-cultured cells were at various stages of differentiation and varied from the 
AFP-producing hepatoblast-like immature cells to the CYP3A4/7-expressing mature 
hepatocyte-like cells. Further research is necessary to obtain a homogeneous functional 
hepatocyte culture from hESCs. The undifferentiated hESCs did not express any mature 
hepatic markers or hepatocyte functions even after co-culture with MLSgt20 cells. 
These findings indicate that MLSgt20 cells can induce the maturation of committed 
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progenitors into hepatocytes, but they cannot directly specify the endodermal fate of 
hESCs. 
CYP3As are the most abundant CYP enzymes in the human liver, and are 
involved in the metabolism of 45-60% of currently used drugs (Wilkinson, 2005, 
Wojnowski, 2004). There are four isoforms in the CYP3A subfamily, namely CYP3A4, 
CYP3A5, CYP3A7, and CYP3A43 (Finta and Zaphiropoulos, 2000, Gellner, et al., 
2001, Westlind, et al., 2001). CYP3A4 is the major CYP3A isoform in the human adult 
liver (Stevens, 2006). However, CYP3A7 is the major component of fetal hepatic CYP 
enzymes, and this isoform switches to CYP3A4 several weeks after birth (Lacroix, et al., 
1997). Although the induction of CYP3A4 is mediated by ligands for the pregnane X 
receptor, constitutive andorostane receptor, and glucocorticoid receptor (GR), CYP3A7 
induction is primarily mediated by the GR pathway, thus suggesting that this isoform 
plays a role in fetal steroid metabolism and homeostasis (Matsunaga, et al., 2004). In 
this study, it was technically impossible to distinguish between CYP3A4 and CYP3A7 
because of the lack of convenient assays to distinguish the CYP3A isoforms. 
In conclusion, hESCs successfully matured into functional hepatocyte-like 
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cells in vitro via co-culturing with the fetal murine hepatic stromal cell line, MLSgt20. 
The hESC-derived hepatocyte-like cells displayed hepatocyte functions, particularly 
CYP3A4/7 activity and the dexamethasone-mediated CYP3A4/7 induction. Our results 
might therefore positively contribute to the advancement of cell transplantation therapy 
and the development of bio-artificial livers, as well as the prediction of the drug 
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Summary of the culture protocol. 
 
Fig. 2 
Morphological features of the cultured cells. Fig. 2a-c show the cell cultures five days 
after cell sorting, and Fig. 2d-h show the morphology 21 days after cell sorting. The 
MLSgt20 cells cultured alone (a, d, and g), the hESC-derived AFP-producing cells 
co-cultured with the MLSgt20 cells (b, e, and h), and the undifferentiated hESCs 
co-cultured with the MLSgt20 cells (c and f) formed cell aggregates and extended over 
Matrigel-coated dishes. The area encircled by the dashed line in Fig. 2h indicates a 
piled-up colony consisting of large, dark, polygonal cells. Scale bars: (a-c), 150 m; 
(d-f), 400 m; (g, h), 50 m. 
 
Fig. 3 
Immunostaining of the MLSgt20 cells cultured alone (a-d) and the hESC-derived 
AFP-producing cells co-cultured with the MLSgt20 cells (e-j). The MLSgt20 cells 
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cultured alone were negative for human AFP, albumin (Alb), or CYP3A4/7 (a-c) and 
positive for murine gp38 (d). The piled-up colonies in the culture of the hESC-derived 
AFP-producing cells with the MLSgt20 cells were positive for AFP (e), albumin (f, g), 
and CYP3A4/7 (h) and negative for gp38 (i). Some of these albumin-positive cells were 
binucleate (g; arrow heads). The area encircled by the dashed line in Fig. 3i indicates 
the piled-up colony. Green fluorescence indicates the expression of AFP, and red 
fluorescence indicates albumin in Fig. 3j. Blue fluorescence indicates DAPI. Scale bars: 
(a-f, h-j), 100 m; (g), 50 m. 
 
Fig. 4 
An RT-PCR analysis of the hESC-derived functional hepatocyte-like cells. Total RNA 
was extracted from the MLSgt20 cells cultured alone (lane 1), the undifferentiated 
hESCs co-cultured with the MLSgt20 cells (lane 2), the hESC-derived AFP-producing 
cells co-cultured with the MLSgt20 cells (lane 3), and an adult human liver (lane 4). 
Nanog and Oct-3/4 served as undifferentiated ESC markers. GATA4 and AFP served as 
immature hepatocyte markers. Albumin, TAT, TO and CYP3A4/7 served as mature 
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Hepatocyte function analyses. The white bars indicate the MLSgt20 cells cultured alone, 
the dotted bars represent the undifferentiated hESCs co-cultured with the MLSgt20 cells, 
the black bars represent the hESC-derived AFP-producing cells co-cultured with the 
MLSgt20 cells, and the gray bars represent the Huh7 cells. (a) Ammonia removal 
abilities were quantified as a percentage of the decreased ammonia concentration after 
24-hour culture. The statistical analysis was performed by Dunnett’s test. *, P<0.05. (b) 
CYP3A4/7 activities were measured in the absence (0.1 M dexamethasone) or 
presence of dexamethasone-mediated induction (50 M dexamethasone). *, P<0.05 by 
Student’s t-test. (c, d) The piled-up colonies of the hESC-derived AFP-producing cells 
co-cultured with MLSgt20 cells were positive for PAS staining, whereas the 
surrounding monolayer cells were negative for PAS staining. Scale bars: (c), 400 m; 
(d), 50 m. 
Fig. 1, T. Ishii et al.	
Fig. 2, T. Ishii et al.	
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